QUIA PHARMA
0.017
SEK
+3.61 %
QUIA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Be the first to follow this company
+3.61%
-55.9%
-33.85%
-75.07%
-73.98%
-80.67%
-99.93%
-99.99%
-100%
QUIA PHARMA operates in medical technology. The company has developed a technological platform that is used to develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.
Read moreMarket cap
25.63M SEK
Turnover
45K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
26.2
2025
Annual report '24
ShowingAll content types
QuiaPEG has submitted a formal application to Nasdaq for the reverse acquisition of Rosemonkey Ltd.
QuiaPEG och Net Zero Infrastucture take next step to a formal license agreement
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools